Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | Suite 305, 9-3151 Lakeshore Rd KELOWNA BC V1W 3S9 |
Tel: | N/A |
Website: | https://doseology.com |
IR: | See website |
Key People | ||
Richard D. Nanula Executive Chairman of the Board, Chief Executive Officer | Brian Zasitko Chief Financial Officer | Assad J. Kazeminy Chief Scientific Officer |
Business Overview |
Doseology Sciences Inc. is a Canada-based company, which is engaged in improving overall health with a focus on mental health through research, development, and sale of its branded functional mushroom products. The Company, along with its wholly owned subsidiary Dose Labs Inc., is building a progressive brand focused on mental health and wellness through nutraceutical products. The Company's functional mushroom products, including tinctures, powders, and supplements, are available on doseology.com and throughout various retail chains across Canada. Its products include Wake, Lion's Mane & Yerba Mate Tincture; Elevate, Lion's Mane & Ginger Tincture; Sleep, Reishi & Chamomile Tincture; Boost, Shiitake & Turmeric Tincture; Zenergy Bundle, and Mind, Mood & Body Bundle. |
Financial Overview |
For the six months ended 31 December 2023, Doseology Sciences Inc revenues increased from C$22K to C$59K. Net loss decreased 64% to C$190K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Salaries and benefits decrease of 84% to C$30K (expense), Management fees decrease from C$68K (expense) to C$0K, Professional fees decrease of 82% to C$9K (expense). |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $0.29M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.08M as of Dec 31, 2023 |
EBITDA (TTM): | -$0.50M as of Dec 31, 2023 |
Net annual income (TTM): | -$1.45M as of Dec 31, 2023 |
Free cash flow (TTM): | -$0.42M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 4,400,515 as of Feb 16, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |